TCA Tanoira Cassagne advised C&C Medical’s S.A. as issuer and Banco de Galicia y Buenos Aires S.A. y Banco Supervielle S.A. as arrangers and placement agents in the issuance of the Series II Notes under the Automatic Authorization Framework for Low-Impact Public Offerings with a nominal value of ARS 4,000,000,000; denominated and payable in Argentine Pesos, which will accrue interest at a floating rate equal to the TAMAR rate with a 0.00% margin, maturing on April 16, 2028 (the “Notes”).

C&C Medical’s S.A. is a company engaged in the distribution of pharmaceuticals, focusing on high-cost products and specialized treatments—including oncology, transplant, and HIV therapies—operating throughout Argentina. It has its own logistics network in the Buenos Aires Metropolitan Area (AMBA) and distributes to the rest of the country through third parties, supplying social security entities, private health insurers, public health agencies, and drugstores. Additionally, it maintains relationships with both domestic and international laboratories for the commercialization and import of specific medications, positioning itself among the leading pharmaceutical distributors in the country.

Legal Advisors to the Transaction: TCA Tanoira Cassagne through a team led by Partners Alexia Rosenthal and Jaime Uranga, and Associates Carolina Mercero, Stefania Lo Valvo and Mario Ignacio Larreguy Revol